Brian L. Wilson's Comments RSS Syndication from SeekingAlpha.com http://seekingalpha.com/user/790170/comments http://seekingalpha.com/article/1421001/comments?source=feed#comment-18673991 18673991 Fri, 10 May 2013 11:04:39 -0400 http://seekingalpha.com/article/1413381/comments?source=feed#comment-18649771 18649771
euro market doesn't seem doable due to expense of manufacturing therapy but we'll just have to see what JJ will do

when do you expect xtandi/sipuleucel-T to happen?]]> Thu, 09 May 2013 18:13:44 -0400
euro market doesn't seem doable due to expense of manufacturing therapy but we'll just have to see what JJ will do

when do you expect xtandi/sipuleucel-T to happen?]]> http://seekingalpha.com/article/1421001/comments?source=feed#comment-18649231 18649231
I'm not sure what we'll see next quarter but it has to be really good to offset what happened today. If they didn't have upward momentum in April, DNDN might have closed even lower]]> Thu, 09 May 2013 17:58:17 -0400
I'm not sure what we'll see next quarter but it has to be really good to offset what happened today. If they didn't have upward momentum in April, DNDN might have closed even lower]]> http://seekingalpha.com/article/1421001/comments?source=feed#comment-18647811 18647811 Thu, 09 May 2013 17:28:51 -0400 http://seekingalpha.com/article/1413381/comments?source=feed#comment-18644141 18644141 Thu, 09 May 2013 16:25:15 -0400 http://seekingalpha.com/article/1413381/comments?source=feed#comment-18634081 18634081 Thu, 09 May 2013 13:41:16 -0400 http://seekingalpha.com/article/1413381/comments?source=feed#comment-18620431 18620431 Thu, 09 May 2013 09:53:24 -0400 http://seekingalpha.com/article/1413381/comments?source=feed#comment-18620261 18620261 Thu, 09 May 2013 09:48:37 -0400 http://seekingalpha.com/article/1388481/comments?source=feed#comment-18312531 18312531 Wed, 01 May 2013 10:34:39 -0400 http://seekingalpha.com/article/1369321/comments?source=feed#comment-18216151 18216151
linked back to this article

http://bit.ly/ZfcvFt]]> Mon, 29 Apr 2013 07:40:50 -0400
linked back to this article

http://bit.ly/ZfcvFt]]> http://seekingalpha.com/article/1379121/comments?source=feed#comment-18215771 18215771
explanation: http://bit.ly/16brmYv]]> Mon, 29 Apr 2013 07:21:37 -0400
explanation: http://bit.ly/16brmYv]]> http://seekingalpha.com/article/1369321/comments?source=feed#comment-18068401 18068401
http://bit.ly/12EkHp5

acthar data supports it, this is going to be an unpleasant shock for some people]]> Thu, 25 Apr 2013 06:55:16 -0400
http://bit.ly/12EkHp5

acthar data supports it, this is going to be an unpleasant shock for some people]]> http://seekingalpha.com/article/1369321/comments?source=feed#comment-18068371 18068371
Anyway, thanks for the detailed piece. I'm long going into earnings for similar reasons. I'm looking for a pretty good short squeeze here]]> Thu, 25 Apr 2013 06:53:59 -0400
Anyway, thanks for the detailed piece. I'm long going into earnings for similar reasons. I'm looking for a pretty good short squeeze here]]> http://seekingalpha.com/article/1359031/comments?source=feed#comment-17947661 17947661
It's an occupied niche. AMRN longs will win if Vascepa continues to eat Lovaza market share, but the pace has been frustrating

If you have $4.00 puts (or whatever you bought), you're going to need something better than sluggish growth to put you in the green]]> Mon, 22 Apr 2013 16:20:08 -0400
It's an occupied niche. AMRN longs will win if Vascepa continues to eat Lovaza market share, but the pace has been frustrating

If you have $4.00 puts (or whatever you bought), you're going to need something better than sluggish growth to put you in the green]]> http://seekingalpha.com/article/1351091/comments?source=feed#comment-17789251 17789251 Thu, 18 Apr 2013 11:41:54 -0400 http://seekingalpha.com/article/1351091/comments?source=feed#comment-17789141 17789141
By the way - "GlaxoSmithKline's (GSK) Lovaza (which according to Adam Feuerstein, generates roughly $1 billion in annual sales)."

it's closer to 1.4 now]]> Thu, 18 Apr 2013 11:38:29 -0400
By the way - "GlaxoSmithKline's (GSK) Lovaza (which according to Adam Feuerstein, generates roughly $1 billion in annual sales)."

it's closer to 1.4 now]]> http://seekingalpha.com/article/1343951/comments?source=feed#comment-17743941 17743941
the broader market is dragging most bio stocks down, but looks like we're in the 6's either way]]> Wed, 17 Apr 2013 13:30:49 -0400
the broader market is dragging most bio stocks down, but looks like we're in the 6's either way]]> http://seekingalpha.com/article/1343951/comments?source=feed#comment-17696031 17696031
I guess I still think the NCE is more important that you do but thanks for the feedback. Much appreciated

-B]]> Tue, 16 Apr 2013 13:44:55 -0400
I guess I still think the NCE is more important that you do but thanks for the feedback. Much appreciated

-B]]> http://seekingalpha.com/article/1343951/comments?source=feed#comment-17688221 17688221 Tue, 16 Apr 2013 10:19:35 -0400 http://seekingalpha.com/article/1343951/comments?source=feed#comment-17685781 17685781
$7-8 pps before earnings is my guess]]> Tue, 16 Apr 2013 09:23:56 -0400
$7-8 pps before earnings is my guess]]> http://seekingalpha.com/article/1341161/comments?source=feed#comment-17656831 17656831 Mon, 15 Apr 2013 14:57:17 -0400 http://seekingalpha.com/article/1341161/comments?source=feed#comment-17656781 17656781 Mon, 15 Apr 2013 14:56:08 -0400 http://seekingalpha.com/article/1341161/comments?source=feed#comment-17656641 17656641
I didn't even put that chart in, it must've been added in during the SA editorial process?]]> Mon, 15 Apr 2013 14:54:01 -0400
I didn't even put that chart in, it must've been added in during the SA editorial process?]]> http://seekingalpha.com/article/1340841/comments?source=feed#comment-17629121 17629121 Mon, 15 Apr 2013 04:49:18 -0400 http://seekingalpha.com/article/1336581/comments?source=feed#comment-17614481 17614481 Sun, 14 Apr 2013 20:20:24 -0400 http://seekingalpha.com/article/1336581/comments?source=feed#comment-17614391 17614391
there's obviously more to the argument]]> Sun, 14 Apr 2013 20:15:31 -0400
there's obviously more to the argument]]> http://seekingalpha.com/article/1336581/comments?source=feed#comment-17614331 17614331
The truth is much less exciting - I'm an individual investor that's fond of biotech/energy stocks & Red Bull]]> Sun, 14 Apr 2013 20:14:32 -0400
The truth is much less exciting - I'm an individual investor that's fond of biotech/energy stocks & Red Bull]]> http://seekingalpha.com/article/1336581/comments?source=feed#comment-17614221 17614221
exactly - it's "expected"

technosphere insulin still the actual product, old device's data for safety will be vital for approval

I really like the new name though]]> Sun, 14 Apr 2013 20:10:30 -0400
exactly - it's "expected"

technosphere insulin still the actual product, old device's data for safety will be vital for approval

I really like the new name though]]> http://seekingalpha.com/article/1336581/comments?source=feed#comment-17614001 17614001
To you (and others), I apologize if your position in MNKD was negatively affected by this article. However, if you're right, obviously you will win in the end anyway.

Lets keep this all non-personal]]> Sun, 14 Apr 2013 20:04:09 -0400
To you (and others), I apologize if your position in MNKD was negatively affected by this article. However, if you're right, obviously you will win in the end anyway.

Lets keep this all non-personal]]> http://seekingalpha.com/article/1336581/comments?source=feed#comment-17613921 17613921
sounds like a great idea, why not buy MNKD on full margin and tell everyone else to do the same. Nothing can go wrong, Afrezza is a guaranteed blockbuster right?

Bio-Wire, Seeking Alpha , Small Cap Network (the main places where this note appeared) are all sites that offer investing opinions based on author's interpretations. Bio-Wire, my site, is more news-centric. My "agenda" is to write on the biotech sector. Some of it is more opinionated (MNKD, QCOR), some of it is more news centric (recently BCRX and SRPT for instance)

I posted my opinion, you (and others) have posted yours. I don't have a position, and most people here do. It's really that simple.

I'll do my best to respond to the people who responded tastefully to my piece, but it may not be instantaneous. I have a lot on my plate right now]]> Sun, 14 Apr 2013 20:01:09 -0400
sounds like a great idea, why not buy MNKD on full margin and tell everyone else to do the same. Nothing can go wrong, Afrezza is a guaranteed blockbuster right?

Bio-Wire, Seeking Alpha , Small Cap Network (the main places where this note appeared) are all sites that offer investing opinions based on author's interpretations. Bio-Wire, my site, is more news-centric. My "agenda" is to write on the biotech sector. Some of it is more opinionated (MNKD, QCOR), some of it is more news centric (recently BCRX and SRPT for instance)

I posted my opinion, you (and others) have posted yours. I don't have a position, and most people here do. It's really that simple.

I'll do my best to respond to the people who responded tastefully to my piece, but it may not be instantaneous. I have a lot on my plate right now]]>